Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.40    -0.05 (-0.30%)
Bid:
16.40
Ask:
16.55
Spread: 0.15 (0.915%)
Market Cap: £131.45m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Board Appointment

28 Nov 2013 07:00

RNS Number : 1229U
Allocate Software PLC
28 November 2013
 



28 November 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Board Appointment

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, has appointed Dr Graham Rich (aged 52) as a Non-Executive Director. He will join the board with effect from 1 December 2013.

 

Dr Rich is an experienced former chief executive of NHS hospitals including a Foundation Trust and a primary care trust (PCT) as well formerly holding a position as Director of Commissioning. He is currently a co-founder of CareTechnica Ltd, a company focusing on the commercialization of medical technology. He has also previously worked on national policy formulation and implementation at the Department of Health. His international experience includes health policy formulation and management consulting in the USA.

 

He has particular interest in patient empowerment, the use of IT in healthcare, improved transparency of outcomes and patient satisfaction to drive performance improvement. His specialities include quality improvement, leadership development, value based healthcare and patient safety.

 

Commenting on the appointment, Terry Osborne, Chairman of Allocate said: "I am delighted to welcome Graham to the Board of Directors of Allocate. Graham is a very talented individual with many years experience in the front line of healthcare as a clinician, a chief executive as well as a policy maker and advisor.

 

"His appointment will further strengthen our Board as Allocate continues to increase its presence and influence in healthcare markets." 

 

Graham Rich commented: "I am delighted to be joining the Board of Allocate Software. The company has a very strong suite of products, and is particularly well placed to help hospitals and other healthcare providers face the challenge of becoming safer and more efficient."

 

Details of Dr Rich's current and previous directorships and partnerships in the past five years are set out below.

 

Current directorships and partnerships

CareTechnica Limited

Talking Health Limited

Quality Practice Limited

No.4 Westbury Park Limited

 

 

Previous directorships and partnerships

Doctor Communication Solutions Limited

 

Dr Rich does not currently hold any ordinary shares in Allocate Software plc.

 

There is no further information in connection with the appointment of Dr Rich to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis/ Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFEDLRLDFIV
Date   Source Headline
11th May 20267:00 amRNSElevra to Transfer Ewoyaa Rights and Obligations
7th May 20267:00 amRNSBinding Scheme Implementation Deed with Huayou
30th Apr 20267:00 amRNSQuarterly Activities and Cash Flow Report
20th Mar 20263:00 pmRNSTR-1 Notification of Major Holdings
20th Mar 20267:00 amRNSParliamentary Ratification of Ewoyaa Mining Lease
17th Mar 20261:03 pmRNSCorporate Funding Update - Amendment
17th Mar 20267:00 amRNSCorporate Funding Update
17th Mar 20267:00 amRNSCorporate Funding Update
13th Mar 20267:09 amRNSHalf-year Financial Report
13th Mar 20267:09 amRNSHalf-year Financial Report
23rd Feb 20267:00 amRNSCorporate Update
19th Feb 20268:27 amRNSASX Trading Halt
29th Jan 20267:00 amRNSQuarterly Activities and Cash Flow Report
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
11th Dec 20257:05 amRNSDirector/PDMR Dealings
11th Dec 20257:00 amRNSUpdate re the Ewoyaa Mining Lease
3rd Dec 20257:00 amRNSTR-1 Notification of Major Holdings
27th Nov 20259:25 amRNSResult of Annual General Meeting
27th Nov 20257:05 amRNSAGM Statement
27th Nov 20257:00 amRNSWithdrawal of AGM Resolution
26th Nov 20257:00 amRNSLong State Funding Update
12th Nov 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
6th Nov 202510:07 amRNSResult of Extraordinary General Meeting
31st Oct 20257:00 amRNSQuarterly Activities and Cash Flow Report
28th Oct 20257:00 amRNSNotice of Annual General Meeting
20th Oct 20257:00 amRNSPronounced Lithium-in-soil Anomalies
7th Oct 20257:28 amRNSNotice of Extraordinary General Meeting
11th Sep 20257:00 amRNS2025 Annual Financial Report
9th Sep 20257:00 amRNSTR-1 Notification of Major Holdings
3rd Sep 20257:00 amRNSCorporate Funding Update
31st Jul 20257:00 amRNSQuarterly Activities and Cash Flow Report
18th Jul 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
11th Jun 20257:00 amRNSLeadership Streamlining and Cost Reductions
22nd May 20257:00 amRNSSpodumene Pegmatite Discovered in Côte d’Ivoire
19th May 20257:00 amRNSLapse of PDMR Options
30th Apr 20257:00 amRNSQuarterly Activities and Cash Flow Report
24th Apr 202511:56 amRNSResponse to Media Reporting
4th Apr 20257:00 amRNSLapse of PDMR Options
14th Mar 20257:00 amRNSHalf-year Financial Report
4th Feb 20254:06 pmRNSResponse to Press Speculation
30th Jan 20257:15 amRNSQuarterly Activities and Cash Flow Report
30th Jan 20257:00 amRNSUpdated Ewoyaa Feldspar Resource Estimate
24th Jan 20257:00 amRNSResignation of Non-Executive Director
23rd Dec 20247:00 amRNSGrant of Performance Rights
16th Dec 20247:00 amRNSTR-1 Notification of Major Holdings
10th Dec 20247:00 amRNSIssue of Equity
29th Nov 20247:51 amRNSResult of AGM
29th Nov 20247:00 amRNSAGM Statement
26th Nov 20247:00 amRNSStatement re Proposed Merger of PLL and SYA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.